Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ciara L Freeman

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Current Oncology Reports|November 29, 2018
Anti-CD20 Directed Therapy of B Cell Lymphomas: Are New Agents Really Better?Ciara L Freeman, Laurie Sehn
British Journal of Haematology|May 20, 2020
COVID-19 and myeloma: what are the implications for now and in the future?Ciara L Freeman, Joseph Mikhael
Current Hematologic Malignancy Reports|February 10, 2016
Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)Ciara L Freeman, John G Gribben
British Journal of Haematology|May 10, 2018
A tale of two antibodies: obinutuzumab versus rituximabCiara L Freeman, Laurie H Sehn
Blood|September 21, 2023
CARs put age in the rearview mirrorCiara L Freeman, Frederick L Locke
Hematology/Oncology Clinics of North America|June 27, 2020
Initial Treatment of High Tumor Burden Follicular LymphomaCiara L Freeman, Laurie H Sehn
Expert Review of Hematology|January 26, 2012
Amonafide: a future in treatment of resistant and secondary acute myeloid leukemia?Ciara L Freeman, Ronan Swords, Francis J Giles
Hematology. American Society of Hematology. Education Program|December 9, 2022
Fitness and frailty in myelomaCharlotte Pawlyn, Abdullah M Khan, Ciara L Freeman
Cancers|March 13, 2024
Utilizing 3D Models to Unravel the Dynamics of Myeloma Plasma Cells' Escape from the Bone Marrow MicroenvironmentStefaan W Verbruggen, Ciara L Freeman, Fiona E Freeman
Hematology. American Society of Hematology. Education Program|December 10, 2021
Treatment of older adult or frail patients with multiple myelomaShakira J Grant, Ciara L Freeman, Ashley E Rosko
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Current Oncology Reports|November 29, 2018
Anti-CD20 Directed Therapy of B Cell Lymphomas: Are New Agents Really Better?Ciara L Freeman, Laurie Sehn
British Journal of Haematology|May 20, 2020
COVID-19 and myeloma: what are the implications for now and in the future?Ciara L Freeman, Joseph Mikhael
Current Hematologic Malignancy Reports|February 10, 2016
Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)Ciara L Freeman, John G Gribben
British Journal of Haematology|May 10, 2018
A tale of two antibodies: obinutuzumab versus rituximabCiara L Freeman, Laurie H Sehn
Blood|September 21, 2023
CARs put age in the rearview mirrorCiara L Freeman, Frederick L Locke
Hematology/Oncology Clinics of North America|June 27, 2020
Initial Treatment of High Tumor Burden Follicular LymphomaCiara L Freeman, Laurie H Sehn
Expert Review of Hematology|January 26, 2012
Amonafide: a future in treatment of resistant and secondary acute myeloid leukemia?Ciara L Freeman, Ronan Swords, Francis J Giles
Hematology. American Society of Hematology. Education Program|December 9, 2022
Fitness and frailty in myelomaCharlotte Pawlyn, Abdullah M Khan, Ciara L Freeman
Cancers|March 13, 2024
Utilizing 3D Models to Unravel the Dynamics of Myeloma Plasma Cells' Escape from the Bone Marrow MicroenvironmentStefaan W Verbruggen, Ciara L Freeman, Fiona E Freeman
Hematology. American Society of Hematology. Education Program|December 10, 2021
Treatment of older adult or frail patients with multiple myelomaShakira J Grant, Ciara L Freeman, Ashley E Rosko
Pageof 7